Skip to content

Comparison of transoral airway and laryngeal mask high-frequency ventilation in painless bronchoscopy: a randomized controlled study.

Comparison of transoral airway and laryngeal mask high-frequency ventilation in painless bronchoscopy: a prospective, randomized controlled, non-inferiority study.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096759
Enrollment
Unknown
Registered
2025-02-06
Start date
2025-05-06
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

painless fiberoptic bronchoscopy,Respiratory related diseases

Interventions

High frequency injection through oropharyngeal airway group (Group O):High frequency ventilation via oropharyngeal airway
high frequency injection through laryngeal mask group (Group L):High frequency ventilation via laryngeal mask

Sponsors

The First Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. ASA Grade I - III; 2. Patients undergoing painless bronchoscopy at selected time; 3. Age 18 years old and above; 4. BMI 18~30 kg/m^2; 5. Agree to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe pulmonary bulla or pneumothorax; 2. Previous lobectomy and tracheal stenosis greater than 50%; 3. Patients with pulse oxygen saturation (SpO2) lower than 90% while inhaling air; 4. Previous asthma; 5. Massive hemoptysis or coagulation dysfunction; 6. Patients with a history of myocardial infarction, uncontrolled hypertension and severe arrhythmia in the past six months; 7. Severe liver and kidney dysfunction; 8. History of nasopharyngeal surgery and nasal deformity; 9. Pregnancy; 10. Allergic to propofol and other narcotic drugs; 11. Participated in other clinical studies within the past 3 months.

Design outcomes

Primary

MeasureTime frame
Incidence of hypoxemia;

Secondary

MeasureTime frame
Incidence of severe hypoxemia;Duration of hypoxemia (seconds) and minimum SpO2 value.;Proportion requiring emergency airway management;Incidence of other adverse events;Bronchoscopy time;Recovery time;

Countries

China

Contacts

Public ContactLi Zhenping

The First Hospital of Jiaxing

lizhenping345@163.com+86 573 82519931

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026